1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Thyrocare Technologies Limited

Thyrocare Technologies Limited

THYROCARE.NS
Thyrocare Technologies LimitedIN flagNational Stock Exchange of India
525.20
INR
+3.55
- -
27.86BMarket Cap

Total Valuation

Thyrocare Technologies Limited carries a market capitalization of 27.86B, placing it among publicly traded companies globally. Its enterprise value stands at 53.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap27.86B
Enterprise Value53.80B

Share Statistics

Thyrocare Technologies Limited currently has 159.16M shares outstanding.

Shares Outstanding159.16M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Thyrocare Technologies Limited trades at a trailing price-to-earnings ratio of 48.22. The price-to-sales ratio is 9.06, and the price-to-book ratio stands at 34.87.

PE Ratio48.22
PS Ratio9.06
PB Ratio34.87
P/TBV Ratio11.70
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Thyrocare Technologies Limited trades at an EV/EBITDA multiple of 37.46 and an EV/FCF ratio of 3,056.03. The EV/Sales ratio of 8.78 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 37.46 provides insight into valuation relative to core operating earnings.

EV / Sales8.78
EV / EBITDA37.46
EV / EBIT37.46
EV / FCF3,056.03

Financial Position

Thyrocare Technologies Limited maintains a current ratio of 3.39, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.65, indicating elevated leverage, while an interest coverage ratio of 62.44 demonstrates strong ability to service its debt obligations.

Current Ratio3.39
Quick Ratio2.02
Debt / Equity8.65
Debt / EBITDA0.35
Interest Coverage62.44

Financial Efficiency

Thyrocare Technologies Limited posts a return on equity of 43.70 and a return on invested capital of 18.44.

Return on Equity (ROE)43.70
Return on Assets (ROA)15.99
Return on Invested Capital (ROIC)18.44
Return on Capital Employed (ROCE)38.77
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.36

Taxes

Over the trailing twelve months, Thyrocare Technologies Limited has paid 352.60M in income taxes, reflecting an effective tax rate of 23.46.

Income Tax352.60M
Effective Tax Rate23.46

Stock Price Statistics

Thyrocare Technologies Limited's stock has gained approximately 58.76663% over the past 52 weeks. The 50-day moving average sits at 426.83, while the 200-day moving average is 427.99.

Beta (5Y)N/A
52-Week Price Change58.76663%
50-Day Moving Average426.83
200-Day Moving Average427.99
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Thyrocare Technologies Limited generated 6.13B in revenue and converted that into 1.15B in net income, yielding earnings per share of 7.22. EBITDA reached 1.44B, while operating income came in at 1.44B.

Revenue6.13B
Gross Profit4.53B
Operating Income1.44B
Pretax Income1.50B
Net Income1.15B
EBITDA1.44B
EBIT1.44B
Earnings Per Share (EPS)7.22

Balance Sheet

Thyrocare Technologies Limited holds 2.22B in cash and equivalents against 506.90M in total debt, resulting in a net debt position of -383.20M. Total book value stands at 1.59B, with working capital of 2.62B providing operational flexibility.

Cash & Cash Equivalents2.22B
Total Debt506.90M
Net Debt-383.20M
Equity (Book Value)1.59B
Book Value Per Share10.02
Working Capital2.62B

Margins

Thyrocare Technologies Limited operates with a gross margin of 73.96, reflecting its pricing power and cost economics. The operating margin of 23.45 and net profit margin of 18.79 provide insight into operational efficiency.

Gross Margin73.96
Operating Margin23.45
Pretax Margin24.54
Profit Margin18.79
EBITDA Margin23.45

Stock Splits

Thyrocare Technologies Limited's most recent stock split took place on November 28, 2025 with a 1:3 split ratio.

Last Split Date11/28/2025
Split Ratio1:3

Scores

Thyrocare Technologies Limited posts an Altman Z-Score of 22.86, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score22.86